Skip to main content
SpringerLink
Log in
Book cover

Disorders of Blood Pressure Regulation pp 259–287Cite as

Sleep Disturbances/Sleep Apnea

  • Chapter
  • First Online:

  • 1888 Accesses

Part of the book series: Updates in Hypertension and Cardiovascular Protection ((UHCP))

Abstract

Obstructive sleep apnea syndrome (OSAS), combining nighttime occurring intermittent obstruction of upper airways with daytime somnolence, is associated with impairment in important mechanisms of cardiovascular regulation, in particular with neural and reflex mechanisms involved in blood pressure (BP) control. The resultant sympathetic activation and the associated metabolic and humoral responses lead to important autonomic and hemodynamic changes (vasoconstriction, fluid retention, elevated blood pressure and blood pressure variability, elevated heart rate, and reduced heart rate variability), which are not only present during the apneic episodes occurring at night but also during daytime wakefulness. The presence of all these conditions, the magnitude of which is directly associated to the severity of OSAS, not only promotes future development of hypertension but also makes hypertension occurring in OSAS more severe and resistant to antihypertensive treatment and associated with profound alterations in day-to-night BP changes. The evidence mentioned above highlights the relevance of OSAS as a risk condition not only for arterial hypertension but also for other cardiovascular diseases. This chapter is aimed at reviewing:

  1. 1.

    The effects of OSAS on different mechanisms involved in integrated cardiovascular modulation (2) The resultant autonomic and hemodynamic responses to these alterations

  2. 2.

    The epidemiological evidence supporting the association of elevated BP with OSAS

  3. 3.

    The prognostic significance of OSAS-related hypertension

  4. 4.

    The diagnostic approach to OSAS-related hypertension

  5. 5.

    Finally, the role of pharmacological and non-pharmacological strategies on OSAS-related hypertension with emphasis on CPAP (i.e., which is known to be effective in reducing the sympathetic nervous system overdrive; a major contributing mechanism for OSAS-related alterations in BP regulation) and whether it may promote achievement of BP control and stabilization of BP levels for improving cardiovascular morbidity and mortality in OSAS patients

This is a preview of subscription content, log in via an institution.

References

  1. Trzebski A (1992) Arterial chemoreceptor reflex and hypertension. Hypertension 19(6 Pt 1):562–566

    Article  CAS  PubMed  Google Scholar 

  2. Narkiewicz K, van de Borne PJ, Montano N et al (1998) Contribution of tonic chemoreflex activation to sympathetic activity and blood pressure in patients with obstructive sleep apnea. Circulation 97(10):943–945

    Article  CAS  PubMed  Google Scholar 

  3. Narkiewicz K, van de Borne PJ, Pesek CA et al (1999) Selective potentiation of peripheral chemoreflex sensitivity in obstructive sleep apnea. Circulation 99(9):1183–1189

    Article  CAS  PubMed  Google Scholar 

  4. Hedner JA, Wilcox I, Laks L et al (1992) A specific and potent pressor effect of hypoxia in patients with sleep apnea. Am Rev Respir Dis 146(5 Pt 1):1240–1245

    Article  CAS  PubMed  Google Scholar 

  5. Parati G, Di Rienzo M, Bonsignore MR et al (1997) Autonomic cardiac regulation in obstructive sleep apnea syndrome: evidence from spontaneous baroreflex analysis during sleep. J Hypertens 15(12 Pt 2):1621–1626

    Article  CAS  PubMed  Google Scholar 

  6. Narkiewicz K, Pesek CA, Kato M et al (1998) Baroreflex control of sympathetic nerve activity and heart rate in obstructive sleep apnea. Hypertension 32(6):1039–1043

    Article  CAS  PubMed  Google Scholar 

  7. Noda A, Nakata S, Koike Y et al (2007) Continuous positive airway pressure improves daytime baroreflex sensitivity and nitric oxide production in patients with moderate to severe obstructive sleep apnea syndrome. Hypertens Res 30(8):669–676

    Article  CAS  PubMed  Google Scholar 

  8. Ryan S, Ward S, Heneghan C, McNicholas WT (2007) Predictors of decreased spontaneous baroreflex sensitivity in obstructive sleep apnea syndrome. Chest 131(4):1100–1107

    Article  PubMed  Google Scholar 

  9. Bonsignore MR, Parati G, Insalaco G et al (2002) Continuous positive airway pressure treatment improves baroreflex control of heart rate during sleep in severe obstructive sleep apnea syndrome. Am J Respir Crit Care Med 166(3):279–286

    Article  PubMed  Google Scholar 

  10. Lombardi C, Parati G, Cortelli P et al (2008) Daytime sleepiness and neural cardiac modulation in sleep-related breathing disorders. J Sleep Res 17(3):263–270

    Article  PubMed  Google Scholar 

  11. Somers VK, Dyken ME, Mark AL, Abboud FM (1993) Sympathetic-nerve activity during sleep in normal subjects. N Engl J Med 328(5):303–307

    Article  CAS  PubMed  Google Scholar 

  12. Somers VK, Dyken ME, Clary MP, Abboud FM (1995) Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 96(4):1897–1904

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Leroy M, Van Surell C, Pilliere R et al (1996) Short-term variability of blood pressure during sleep in snorers with or without apnea. Hypertension 28(6):937–943

    Article  CAS  PubMed  Google Scholar 

  14. Shiomi T, Guilleminault C, Sasanabe R et al (1996) Augmented very low frequency component of heart rate variability during obstructive sleep apnea. Sleep 19(5):370–377

    Article  CAS  PubMed  Google Scholar 

  15. Narkiewicz K, van de Borne PJ, Cooley RL et al (1998) Sympathetic activity in obese subjects with and without obstructive sleep apnea. Circulation 98(8):772–776

    Article  CAS  PubMed  Google Scholar 

  16. Ali NJ, Davies RJ, Fleetham JA, Stradling JR (1992) The acute effects of continuous positive airway pressure and oxygen administration on blood pressure during obstructive sleep apnea. Chest 101(6):1526–1532

    Article  CAS  PubMed  Google Scholar 

  17. Narkiewicz K, Kato M, Phillips BG et al (1999) Nocturnal continuous positive airway pressure decreases daytime sympathetic traffic in obstructive sleep apnea. Circulation 100(23):2332–2335

    Article  CAS  PubMed  Google Scholar 

  18. Gonzaga CC, Gaddam KK, Ahmed MI et al (2010) Severity of obstructive sleep apnea is related to aldosterone status in subjects with resistant hypertension. J Clin Sleep Med 6(4):363–368

    PubMed  PubMed Central  Google Scholar 

  19. Pimenta E, Calhoun DA, Oparil S (2009) Sleep apnea, aldosterone, and resistant hypertension. Prog Cardiovasc Dis 51(5):371–380

    Article  CAS  PubMed  Google Scholar 

  20. Goodfriend TL, Calhoun DA (2004) Resistant hypertension, obesity, sleep apnea, and aldosterone: theory and therapy. Hypertension 43(3):518–524

    Article  CAS  PubMed  Google Scholar 

  21. Calhoun DA, Nishizaka MK, Zaman MA, Harding SM (2004) Aldosterone excretion among subjects with resistant hypertension and symptoms of sleep apnea. Chest 125(1):112–117

    Article  CAS  PubMed  Google Scholar 

  22. Pratt-Ubunama MN, Nishizaka MK, Boedefeld RL et al (2007) Plasma aldosterone is related to severity of obstructive sleep apnea in subjects with resistant hypertension. Chest 131(2):453–459

    Article  CAS  PubMed  Google Scholar 

  23. Calhoun DA (2010) Obstructive sleep apnea and hypertension. Curr Hypertens Rep 12(3):189–195

    Article  PubMed  Google Scholar 

  24. Dudenbostel T, Calhoun DA (2012) Resistant hypertension, obstructive sleep apnoea and aldosterone. J Hum Hypertens 26(5):281–287

    Article  CAS  PubMed  Google Scholar 

  25. Gaddam K, Pimenta E, Thomas SJ et al (2010) Spironolactone reduces severity of obstructive sleep apnoea in patients with resistant hypertension: a preliminary report. J Hum Hypertens 24(8):532–537

    Article  CAS  PubMed  Google Scholar 

  26. Kato M, Roberts-Thomson P, Phillips BG et al (2000) Impairment of endothelium-dependent vasodilation of resistance vessels in patients with obstructive sleep apnea. Circulation 102(21):2607–2610

    Article  CAS  PubMed  Google Scholar 

  27. Ip MS, Tse HF, Lam B et al (2004) Endothelial function in obstructive sleep apnea and response to treatment. Am J Respir Crit Care Med 169(3):348–353

    Article  PubMed  Google Scholar 

  28. Jelic S, Lederer DJ, Adams T et al (2010) Vascular inflammation in obesity and sleep apnea. Circulation 121(8):1014–1021

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Butt M, Khair OA, Dwivedi G et al (2011) Myocardial perfusion by myocardial contrast echocardiography and endothelial dysfunction in obstructive sleep apnea. Hypertension 58(3):417–424

    Article  CAS  PubMed  Google Scholar 

  30. Jelic S, Padeletti M, Kawut SM et al (2008) Inflammation, oxidative stress, and repair capacity of the vascular endothelium in obstructive sleep apnea. Circulation 117(17):2270–2278

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Dyugovskaya L, Lavie P, Lavie L (2002) Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am J Respir Crit Care Med 165(7):934–939

    Article  PubMed  Google Scholar 

  32. Minoguchi K, Yokoe T, Tazaki T et al (2005) Increased carotid intima-media thickness and serum inflammatory markers in obstructive sleep apnea. Am J Respir Crit Care Med 172(5):625–630

    Article  PubMed  Google Scholar 

  33. Phillips BG, Narkiewicz K, Pesek CA et al (1999) Effects of obstructive sleep apnea on endothelin-1 and blood pressure. J Hypertens 17(1):61–66

    Article  CAS  PubMed  Google Scholar 

  34. Kanagy NL, Walker BR, Nelin LD (2001) Role of endothelin in intermittent hypoxia-induced hypertension. Hypertension 37(2 Part 2):511–515

    Article  CAS  PubMed  Google Scholar 

  35. Ryan S, Taylor CT, McNicholas WT (2005) Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation 112(17):2660–2667

    Article  CAS  PubMed  Google Scholar 

  36. Shamsuzzaman AS, Winnicki M, Lanfranchi P et al (2002) Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation 105(21):2462–2464

    Article  CAS  PubMed  Google Scholar 

  37. Yokoe T, Minoguchi K, Matsuo H et al (2003) Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 107(8):1129–1134

    Article  CAS  PubMed  Google Scholar 

  38. Ohga E, Nagase T, Tomita T et al (1999) Increased levels of circulating ICAM-1, VCAM-1, and L-selectin in obstructive sleep apnea syndrome. J Appl Physiol 87(1):10–14

    Article  CAS  PubMed  Google Scholar 

  39. Doonan RJ, Scheffler P, Lalli M et al (2011) Increased arterial stiffness in obstructive sleep apnea: a systematic review. Hypertens Res 34(1):23–32

    Article  PubMed  Google Scholar 

  40. Tsioufis C, Thomopoulos K, Dimitriadis K et al (2007) The incremental effect of obstructive sleep apnoea syndrome on arterial stiffness in newly diagnosed essential hypertensive subjects. J Hypertens 25(1):141–146

    Article  CAS  PubMed  Google Scholar 

  41. Drager LF, Bortolotto LA, Figueiredo AC et al (2007) Obstructive sleep apnea, hypertension, and their interaction on arterial stiffness and heart remodeling. Chest 131(5):1379–1386

    Article  PubMed  Google Scholar 

  42. Shiina K, Tomiyama H, Takata Y et al (2006) Concurrent presence of metabolic syndrome in obstructive sleep apnea syndrome exacerbates the cardiovascular risk: a sleep clinic cohort study. Hypertens Res 29(6):433–441

    Article  PubMed  Google Scholar 

  43. Nagahama H, Soejima M, Uenomachi H et al (2004) Pulse wave velocity as an indicator of atherosclerosis in obstructive sleep apnea syndrome patients. Intern Med 43(3):184–188

    Article  PubMed  Google Scholar 

  44. Kohler M, Pepperell JC, Casadei B et al (2008) CPAP and measures of cardiovascular risk in males with OSAS. Eur Respir J 32(6):1488–1496

    Article  CAS  PubMed  Google Scholar 

  45. Drager LF, Bortolotto LA, Figueiredo AC et al (2007) Effects of continuous positive airway pressure on early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med 176(7):706–712

    Article  CAS  PubMed  Google Scholar 

  46. Rasche K, Keller T, Tautz B et al (2010) Obstructive sleep apnea and type 2 diabetes. Eur J Med Res 15(Suppl 2):152–156

    PubMed  PubMed Central  Google Scholar 

  47. Basoglu OK, Sarac F, Sarac S et al (2011) Metabolic syndrome, insulin resistance, fibrinogen, homocysteine, leptin, and C-reactive protein in obese patients with obstructive sleep apnea syndrome. Ann Thoracic Med 6(3):120–125

    Article  CAS  Google Scholar 

  48. Zirlik S, Hauck T, Fuchs FS et al (2011) Leptin, obestatin and apelin levels in patients with obstructive sleep apnoea syndrome. Med Sci Monit 17(3):CR159–CR164

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Bonsignore MR, Esquinas C, Barcelo A et al (2012) Metabolic syndrome, insulin resistance and sleepiness in real-life obstructive sleep apnoea. Eur Respir J 39(5):1136–1143

    Article  CAS  PubMed  Google Scholar 

  50. Phillips BG, Kato M, Narkiewicz K et al (2000) Increases in leptin levels, sympathetic drive, and weight gain in obstructive sleep apnea. Am J Physiol Heart Circ Physiol 279(1):H234–H237

    Article  CAS  PubMed  Google Scholar 

  51. Mancia G, De Backer G, Dominiczak A et al (2007) 2007 Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 25(6):1105–1187

    Article  CAS  PubMed  Google Scholar 

  52. Grote L, Hedner J, Peter JH (2000) Sleep-related breathing disorder is an independent risk factor for uncontrolled hypertension. J Hypertens 18(6):679–685

    Article  CAS  PubMed  Google Scholar 

  53. Peppard PE, Young T, Palta M, Skatrud J (2000) Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 342(19):1378–1384

    Article  CAS  PubMed  Google Scholar 

  54. Nieto FJ, Young TB, Lind BK et al (2000) Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA 283(14):1829–1836

    Article  CAS  PubMed  Google Scholar 

  55. Coccagna G, Mantovani M, Brignani F et al (1972) Continuous recording of the pulmonary and systemic arterial pressure during sleep in syndromes of hypersomnia with periodic breathing. Bull Physiopathol Respir (Nancy) 8(5):1159–1172

    CAS  Google Scholar 

  56. Steinhorst AP, Goncalves SC, Oliveira AT et al (2014) Influence of sleep apnea severity on blood pressure variability of patients with hypertension. Sleep Breath 18(2):397–401

    Article  PubMed  Google Scholar 

  57. Lavie P, Herer P, Hoffstein V (2000) Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study. BMJ 320(7233):479–482

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Davies CW, Crosby JH, Mullins RL et al (2000) Case-control study of 24 hour ambulatory blood pressure in patients with obstructive sleep apnoea and normal matched control subjects. Thorax 55(9):736–740

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Pankow W, Nabe B, Lies A et al (1997) Influence of sleep apnea on 24-hour blood pressure. Chest 112(5):1253–1258

    Article  CAS  PubMed  Google Scholar 

  60. Portaluppi F, Provini F, Cortelli P et al (1997) Undiagnosed sleep-disordered breathing among male nondippers with essential hypertension. J Hypertens 15(11):1227–1233

    Article  CAS  PubMed  Google Scholar 

  61. Narkiewicz K, Montano N, Cogliati C et al (1998) Altered cardiovascular variability in obstructive sleep apnea. Circulation 98(11):1071–1077

    Article  CAS  PubMed  Google Scholar 

  62. Bixler EO, Vgontzas AN, Lin HM et al (2000) Association of hypertension and sleep-disordered breathing. Arch Intern Med 160(15):2289–2295

    Article  CAS  PubMed  Google Scholar 

  63. Duran J, Esnaola S, Rubio R, Iztueta A (2001) Obstructive sleep apnea-hypopnea and related clinical features in a population-based sample of subjects aged 30 to 70 yr. Am J Respir Crit Care Med 163(3 Pt 1):685–689

    Article  CAS  PubMed  Google Scholar 

  64. Tanigawa T, Tachibana N, Yamagishi K et al (2004) Relationship between sleep-disordered breathing and blood pressure levels in community-based samples of Japanese men. Hypertens Res 27(7):479–484

    Article  PubMed  Google Scholar 

  65. Young T, Peppard P, Palta M et al (1997) Population-based study of sleep-disordered breathing as a risk factor for hypertension. Arch Intern Med 157(15):1746–1752

    Article  CAS  PubMed  Google Scholar 

  66. Kiely JL, McNicholas WT (2000) Cardiovascular risk factors in patients with obstructive sleep apnoea syndrome. Eur Respir J 16(1):128–313

    Article  CAS  PubMed  Google Scholar 

  67. Baguet JP, Hammer L, Levy P, Pierre H, Rossini E, Mouret S et al (2005) Night-time and diastolic hypertension are common and underestimated conditions in newly diagnosed apnoeic patients. J Hypertens 23(3):521–527

    Article  CAS  PubMed  Google Scholar 

  68. Garrison RJ, Kannel WB, Stokes J 3rd, Castelli WP (1987) Incidence and precursors of hypertension in young adults: the Framingham Offspring Study. Prev Med 16(2):235–251

    Article  CAS  PubMed  Google Scholar 

  69. Bramlage P, Pittrow D, Wittchen HU et al (2004) Hypertension in overweight and obese primary care patients is highly prevalent and poorly controlled. Am J Hypertens 17(10):904–910

    Article  PubMed  Google Scholar 

  70. O’Connor GT, Caffo B, Newman AB et al (2009) Prospective study of sleep-disordered breathing and hypertension: the Sleep Heart Health Study. Am J Respir Crit Care Med 179(12):1159–1164

    Article  PubMed  PubMed Central  Google Scholar 

  71. Cano-Pumarega I, Duran-Cantolla J, Aizpuru F et al (2011) Obstructive sleep apnea and systemic hypertension: longitudinal study in the general population: the Vitoria Sleep Cohort. Am J Respir Crit Care Med 184(11):1299–1304

    Article  PubMed  Google Scholar 

  72. Somers VK, White DP, Amin R et al (2008) Sleep apnea and cardiovascular disease: an American Heart Association/American College Of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council On Cardiovascular Nursing. In collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health). Circulation 118(10):1080–1111

    Article  PubMed  Google Scholar 

  73. Calhoun DA, Jones D, Textor S et al (2008) Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension 51(6):1403–1419

    Article  CAS  PubMed  Google Scholar 

  74. Logan AG, Perlikowski SM, Mente A et al (2001) High prevalence of unrecognized sleep apnoea in drug-resistant hypertension. J Hypertens 19(12):2271–2277

    Article  CAS  PubMed  Google Scholar 

  75. Hla KM, Young T, Finn L et al (2008) Longitudinal association of sleep-disordered breathing and nondipping of nocturnal blood pressure in the Wisconsin Sleep Cohort Study. Sleep 31(6):795–800

    Article  PubMed  PubMed Central  Google Scholar 

  76. Lavie-Nevo K, Pillar G (2006) Evening-morning differences in blood pressure in sleep apnea syndrome: effect of gender. Am J Hypertens 19(10):1064–1069

    Article  PubMed  Google Scholar 

  77. de la Sierra A, Segura J, Banegas JR et al (2011) Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring. Hypertension 57(5):898–902

    Article  PubMed  CAS  Google Scholar 

  78. Muxfeldt ES, Cardoso CR, Salles GF (2009) Prognostic value of nocturnal blood pressure reduction in resistant hypertension. Arch Intern Med 169(9):874–880

    Article  PubMed  Google Scholar 

  79. Muxfeldt ES, Bloch KV, Nogueira AR, Salles GF (2003) Twenty-four hour ambulatory blood pressure monitoring pattern of resistant hypertension. Blood Press Monit 8(5):181–185

    Article  PubMed  Google Scholar 

  80. Barbe F, Duran-Cantolla J, Capote F et al (2010) Long-term effect of continuous positive airway pressure in hypertensive patients with sleep apnea. Am J Respir Crit Care Med 181(7):718–726

    Article  PubMed  Google Scholar 

  81. Barbe F, Duran-Cantolla J, Sanchez-de-la-Torre M et al (2012) Effect of continuous positive airway pressure on the incidence of hypertension and cardiovascular events in nonsleepy patients with obstructive sleep apnea: a randomized controlled trial. JAMA 307(20):2161–2168

    Article  CAS  PubMed  Google Scholar 

  82. McNicholas WT, Bonsigore MR (2007) Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities. Eur Respir J 29(1):156–178

    Article  CAS  PubMed  Google Scholar 

  83. Otto ME, Belohlavek M, Romero-Corral A et al (2007) Comparison of cardiac structural and functional changes in obese otherwise healthy adults with versus without obstructive sleep apnea. Am J Cardiol 99(9):1298–1302

    Article  PubMed  Google Scholar 

  84. Tavil Y, Kanbay A, Sen N et al (2007) Comparison of right ventricular functions by tissue Doppler imaging in patients with obstructive sleep apnea syndrome with or without hypertension. Int J Card Imaging 23(4):469–477

    Article  Google Scholar 

  85. Agrawal V, Vanhecke TE, Rai B et al (2009) Albuminuria and renal function in obese adults evaluated for obstructive sleep apnea. Nephron Clin Pract 113(3):c140–c147

    Article  PubMed  Google Scholar 

  86. Sim JJ, Rasgon SA, Derose SF (2010) Review article: managing sleep apnoea in kidney diseases. Nephrology (Carlton) 15(2):146–152

    Article  Google Scholar 

  87. Yaggi HK, Concato J, Kernan WN et al (2005) Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 353(19):2034–2041

    Article  CAS  PubMed  Google Scholar 

  88. Selim B, Won C, Yaggi HK (2010) Cardiovascular consequences of sleep apnea. Clin Chest Med 31(2):203–220

    Article  PubMed  Google Scholar 

  89. Gottlieb DJ, Yenokyan G, Newman AB et al (2010) Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure: the sleep heart health study. Circulation 122(4):352–360

    Article  PubMed  PubMed Central  Google Scholar 

  90. Redline S, Yenokyan G, Gottlieb DJ et al (2010) Obstructive sleep apnea-hypopnea and incident stroke: the sleep heart health study. Am J Respir Crit Care Med 182(2):269–277

    Article  PubMed  PubMed Central  Google Scholar 

  91. Capampangan DJ, Wellik KE, Parish JM et al (2010) Is obstructive sleep apnea an independent risk factor for stroke? A critically appraised topic. Neurologist 16(4):269–273

    Article  PubMed  Google Scholar 

  92. Marshall NS, Wong KK, Liu PY et al (2008) Sleep apnea as an independent risk factor for all-cause mortality: the Busselton Health Study. Sleep 31(8):1079–1085

    PubMed  PubMed Central  Google Scholar 

  93. Young T, Finn L, Peppard PE et al (2008) Sleep disordered breathing and mortality: eighteen-year follow-up of the Wisconsin sleep cohort. Sleep 31(8):1071–1078

    PubMed  PubMed Central  Google Scholar 

  94. Persell SD (2011) Prevalence of resistant hypertension in the United States, 2003-2008. Hypertension 57(6):1076–1080

    Article  CAS  PubMed  Google Scholar 

  95. Egan BM, Zhao Y, Axon RN et al (2011) Uncontrolled and apparent treatment resistant hypertension in the United States, 1988 to 2008. Circulation 124(9):1046–1058

    Article  PubMed  PubMed Central  Google Scholar 

  96. James PA, Oparil S, Carter BL et al (2014) 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 311(5):507–520

    Article  CAS  PubMed  Google Scholar 

  97. Mancia G, Fagard R, Narkiewicz K et al (2013) 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 31(7):1281–1357

    Article  CAS  PubMed  Google Scholar 

  98. Wolf J, Hering D, Narkiewicz K (2010) Non-dipping pattern of hypertension and obstructive sleep apnea syndrome. Hypertens Res 33(9):867–871

    Article  PubMed  Google Scholar 

  99. Staessen JA, Thijs L, Fagard R et al (1999) Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators. JAMA 282(6):539–546

    Article  CAS  PubMed  Google Scholar 

  100. Sega R, Facchetti R, Bombelli M et al (2005) Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study. Circulation 111(14):1777–1783

    Article  PubMed  Google Scholar 

  101. Kikuya M, Ohkubo T, Asayama K et al (2005) Ambulatory blood pressure and 10-year risk of cardiovascular and noncardiovascular mortality: the Ohasama study. Hypertension 45(2):240–245

    Article  CAS  PubMed  Google Scholar 

  102. Fagard RH, Celis H, Thijs L et al (2008) Daytime and nighttime blood pressure as predictors of death and cause-specific cardiovascular events in hypertension. Hypertension 51(1):55–61

    Article  CAS  PubMed  Google Scholar 

  103. Boggia J, Li Y, Thijs L et al (2007) Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study. Lancet 370(9594):1219–1229

    Article  PubMed  Google Scholar 

  104. Hansen TW, Li Y, Boggia J, Thijs L et al (2011) Predictive role of the nighttime blood pressure. Hypertension 57(1):3–10

    Article  CAS  PubMed  Google Scholar 

  105. Clement DL, De Buyzere ML, De Bacquer DA et al (2003) Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. N Engl J Med 348(24):2407–2415

    Article  PubMed  Google Scholar 

  106. Fagard RH, Van Den Broeke C, De Cort P (2005) Prognostic significance of blood pressure measured in the office, at home and during ambulatory monitoring in older patients in general practice. J Hum Hypertens 19(10):801–807

    Article  CAS  PubMed  Google Scholar 

  107. Redon J, Campos C, Narciso ML et al (1998) Prognostic value of ambulatory blood pressure monitoring in refractory hypertension: a prospective study. Hypertension 31(2):712–718

    Article  CAS  PubMed  Google Scholar 

  108. Dolan E, Stanton A, Thijs L et al (2005) Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study. Hypertension 46(1):156–161

    Article  CAS  PubMed  Google Scholar 

  109. Hansen TW, Jeppesen J, Rasmussen S et al (2005) Ambulatory blood pressure and mortality: a population-based study. Hypertension 45(4):499–504

    Article  CAS  PubMed  Google Scholar 

  110. Sander D, Kukla C, Klingelhofer J et al (2000) Relationship between circadian blood pressure patterns and progression of early carotid atherosclerosis: A 3-year follow-up study. Circulation 102(13):1536–1541

    Article  CAS  PubMed  Google Scholar 

  111. Lurbe E, Redon J, Kesani A et al (2002) Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes. N Engl J Med 347(11):797–805

    Article  CAS  PubMed  Google Scholar 

  112. Metoki H, Ohkubo T, Kikuya M et al (2006) Prognostic significance for stroke of a morning pressor surge and a nocturnal blood pressure decline: the Ohasama study. Hypertension 47(2):149–154

    Article  CAS  PubMed  Google Scholar 

  113. Parati G, Lombardi C, Hedner J et al (2012) Position paper on the management of patients with obstructive sleep apnea and hypertension: joint recommendations by the European Society of Hypertension, by the European Respiratory Society and by the members of European COST (COoperation in Scientific and Technological research) ACTION B26 on obstructive sleep apnea. J Hypertens 30(4):633–646

    Article  CAS  PubMed  Google Scholar 

  114. Parati G, Lombardi C, Hedner J et al (2013) Recommendations for the management of patients with obstructive sleep apnoea and hypertension. Eur Respir J 41(3):523–538

    Article  CAS  PubMed  Google Scholar 

  115. O’Brien E, Asmar R, Beilin L, Imai Y, Mallion JM, Mancia G et al (2003) European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens 21(5):821–848. Epub 2003/04/26

    Article  PubMed  Google Scholar 

  116. Oikawa T, Obara T, Ohkubo T et al (2006) Characteristics of resistant hypertension determined by self-measured blood pressure at home and office blood pressure measurements: the J-HOME study. J Hypertens 24(9):1737–1743

    Article  CAS  PubMed  Google Scholar 

  117. de la Sierra A, Banegas JR, Oliveras A et al (2012) Clinical differences between resistant hypertensives and patients treated and controlled with three or less drugs. J Hypertens 30(6):1211–1216

    Article  PubMed  CAS  Google Scholar 

  118. Pickering TG, Davidson K, Gerin W, Schwartz JE (2002) Masked hypertension. Hypertension 40(6):795–796

    Article  CAS  PubMed  Google Scholar 

  119. Parati G, Ulian L, Santucciu C et al (1998) Difference between clinic and daytime blood pressure is not a measure of the white coat effect. Hypertension 31(5):1185–1189

    Article  CAS  PubMed  Google Scholar 

  120. Muxfeldt ES, Bloch KV, Nogueira Ada R, Salles GF (2005) True resistant hypertension: is it possible to be recognized in the office? Am J Hypertens 18(12 Pt 1):1534–1540

    Article  PubMed  Google Scholar 

  121. Oliveras A, Armario P, Hernandez-Del Rey R et al (2010) Urinary albumin excretion is associated with true resistant hypertension. J Hum Hypertens 24(1):27–33

    Article  CAS  PubMed  Google Scholar 

  122. Pierdomenico SD, Lapenna D, Bucci A et al (2005) Cardiovascular outcome in treated hypertensive patients with responder, masked, false resistant, and true resistant hypertension. Am J Hypertens 18(11):1422–1428

    Article  PubMed  Google Scholar 

  123. Salles GF, Cardoso CR, Muxfeldt ES (2008) Prognostic influence of office and ambulatory blood pressures in resistant hypertension. Arch Intern Med 168(21):2340–2346

    Article  PubMed  Google Scholar 

  124. Cuspidi C, Macca G, Sampieri L et al (2001) High prevalence of cardiac and extracardiac target organ damage in refractory hypertension. J Hypertens 19(11):2063–2070

    Article  CAS  PubMed  Google Scholar 

  125. Moser M, Setaro JF (2006) Clinical practice. Resistant or difficult-to-control hypertension. N Engl J Med 355(4):385–392

    Article  CAS  PubMed  Google Scholar 

  126. Johansson K, Hemmingsson E, Harlid R et al (2011) Longer term effects of very low energy diet on obstructive sleep apnoea in cohort derived from randomised controlled trial: prospective observational follow-up study. BMJ 342:d3017

    Article  PubMed  PubMed Central  Google Scholar 

  127. Yee BJ, Phillips CL, Banerjee D et al (2007) The effect of sibutramine-assisted weight loss in men with obstructive sleep apnoea. Int J Obes 31(1):161–168

    Article  CAS  Google Scholar 

  128. Pannain S, Mokhlesi B (2010) Bariatric surgery and its impact on sleep architecture, sleep-disordered breathing, and metabolism. Best Pract Res Clin Endocrinol Metab 24(5):745–761

    Article  PubMed  Google Scholar 

  129. Buchwald H, Avidor Y, Braunwald E et al (2004) Bariatric surgery: a systematic review and meta-analysis. JAMA 292(14):1724–1737

    Article  CAS  PubMed  Google Scholar 

  130. Leech JA, Onal E, Lopata M (1992) Nasal CPAP continues to improve sleep-disordered breathing and daytime oxygenation over long-term follow-up of occlusive sleep apnea syndrome. Chest 102(6):1651–1655

    Article  CAS  PubMed  Google Scholar 

  131. Kribbs NB, Pack AI, Kline LR et al (1993) Effects of one night without nasal CPAP treatment on sleep and sleepiness in patients with obstructive sleep apnea. Am Rev Respir Dis 147(5):1162–1168

    Article  CAS  PubMed  Google Scholar 

  132. Bradley TD, Floras JS (2009) Obstructive sleep apnoea and its cardiovascular consequences. Lancet 373(9657):82–93

    Article  PubMed  Google Scholar 

  133. Alajmi M, Mulgrew AT, Fox J et al (2007) Impact of continuous positive airway pressure therapy on blood pressure in patients with obstructive sleep apnea hypopnea: a meta-analysis of randomized controlled trials. Lung 185(2):67–72

    Article  CAS  PubMed  Google Scholar 

  134. Haentjens P, Van Meerhaeghe A, Moscariello A et al (2007) The impact of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea syndrome: evidence from a meta-analysis of placebo-controlled randomized trials. Arch Intern Med 167(8):757–764

    Article  PubMed  Google Scholar 

  135. Bazzano LA, Khan Z, Reynolds K, He J (2007) Effect of nocturnal nasal continuous positive airway pressure on blood pressure in obstructive sleep apnea. Hypertension 50(2):417–423

    Article  CAS  PubMed  Google Scholar 

  136. Becker HF, Jerrentrup A, Ploch T et al (2003) Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 107(1):68–73

    Article  PubMed  Google Scholar 

  137. Logan AG, Tkacova R, Perlikowski SM et al (2003) Refractory hypertension and sleep apnoea: effect of CPAP on blood pressure and baroreflex. Eur Respir J 21(2):241–247

    Article  CAS  PubMed  Google Scholar 

  138. Dernaika TA, Kinasewitz GT, Tawk MM (2009) Effects of nocturnal continuous positive airway pressure therapy in patients with resistant hypertension and obstructive sleep apnea. J Clin Sleep Med 5(2):103–107

    PubMed  PubMed Central  Google Scholar 

  139. Lozano L, Tovar JL, Sampol G et al (2010) Continuous positive airway pressure treatment in sleep apnea patients with resistant hypertension: a randomized, controlled trial. J Hypertens 28(10):2161–2168

    Article  CAS  PubMed  Google Scholar 

  140. Hu X, Fan J, Chen S et al (2015) The role of continuous positive airway pressure in blood pressure control for patients with obstructive sleep apnea and hypertension: a meta-analysis of randomized controlled trials. J Clin Hypertens (Greenwich) 17(3):215–222

    Article  CAS  Google Scholar 

  141. Martinez-Garcia MA, Capote F, Campos-Rodriguez F et al (2013) Effect of CPAP on blood pressure in patients with obstructive sleep apnea and resistant hypertension: the HIPARCO randomized clinical trial. JAMA 310(22):2407–2415

    Article  CAS  PubMed  Google Scholar 

  142. Muxfeldt ES, Margallo V, Costa LM et al (2015) Effects of continuous positive airway pressure treatment on clinic and ambulatory blood pressures in patients with obstructive sleep apnea and resistant hypertension: a randomized controlled trial. Hypertension 65(4):736–742

    Article  CAS  PubMed  Google Scholar 

  143. Sekizuka H, Osada N, Akashi YJ (2016) Effect of oral appliance therapy on blood pressure in Japanese patients with obstructive sleep apnea. Clin Exp Hypertens 38(4):404–408

    Article  CAS  PubMed  Google Scholar 

  144. Andren A, Hedberg P, Walker-Engstrom ML et al (2013) Effects of treatment with oral appliance on 24-h blood pressure in patients with obstructive sleep apnea and hypertension: a randomized clinical trial. Sleep Breath 17(2):705–712

    Article  PubMed  Google Scholar 

  145. Iftikhar IH, Hays ER, Iverson MA et al (2013) Effect of oral appliances on blood pressure in obstructive sleep apnea: a systematic review and meta-analysis. J Clin Sleep Med 9(2):165–174

    PubMed  PubMed Central  Google Scholar 

  146. Coruzzi P, Gualerzi M, Bernkopf E et al (2006) Autonomic cardiac modulation in obstructive sleep apnea: effect of an oral jaw-positioning appliance. Chest 130(5):1362–1368

    Article  PubMed  Google Scholar 

  147. White DP, Shafazand S (2013) Mandibular advancement device vs. CPAP in the treatment of obstructive sleep apnea: are they equally effective in Short term health outcomes? J Clin Sleep Med 9(9):971–972

    PubMed  PubMed Central  Google Scholar 

  148. DiBona GF, Kopp UC (1997) Neural control of renal function. Physiol Rev 77(1):75–197

    Article  CAS  PubMed  Google Scholar 

  149. Doumas M, Faselis C, Papademetriou V (2011) Renal sympathetic denervation in hypertension. Curr Opin Nephrol Hypertens 20(6):647–653

    Article  PubMed  Google Scholar 

  150. Schlaich MP, Sobotka PA, Krum H et al (2009) Renal sympathetic-nerve ablation for uncontrolled hypertension. N Engl J Med 361(9):932–934

    Article  CAS  PubMed  Google Scholar 

  151. Witkowski A, Prejbisz A, Florczak E et al (2011) Effects of renal sympathetic denervation on blood pressure, sleep apnea course, and glycemic control in patients with resistant hypertension and sleep apnea. Hypertension 58(4):559–665

    Article  CAS  PubMed  Google Scholar 

  152. Ziegler MG, Milic M, Sun P (2011) Antihypertensive therapy for patients with obstructive sleep apnea. Curr Opin Nephrol Hypertens 20(1):50–55

    Article  CAS  PubMed  Google Scholar 

  153. Pimenta E, Calhoun DA (2010) Treatment of resistant hypertension. J Hypertens 28(11):2194–2195

    Article  CAS  PubMed  Google Scholar 

  154. Kasiakogias A, Tsioufis C, Thomopoulos C, Andrikou I, Aragiannis D, Dimitriadis K et al (2015) Evening versus morning dosing of antihypertensive drugs in hypertensive patients with sleep apnoea: a cross-over study. J Hypertens 33(2):393–400

    Article  CAS  PubMed  Google Scholar 

  155. Kario K, Kuwabara M, Hoshide S et al (2014) Effects of nighttime single-dose administration of vasodilating vs sympatholytic antihypertensive agents on sleep blood pressure in hypertensive patients with sleep apnea syndrome. J Clin Hypertens (Greenwich) 16(6):459–466

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy

    Gianfranco Parati

  2. Department of Cardiovascular, Neural and Metabolic Sciences, S.Luca Hospital, IRCCS Istituto Auxologico Italiano & University of Milan-Bicocca, Piazza Brescia 20, Milan, 20149, Italy

    Gianfranco Parati, Carolina Lombardi & Juan Eugenio Ochoa

  3. Department of Hypertension and Diabetology, Medical University of Gdansk, Gdansk, Poland

    Krzysztof Narkiewicz & Jacek Wolf

Authors
  1. Gianfranco Parati
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Carolina Lombardi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Krzysztof Narkiewicz
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jacek Wolf
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Juan Eugenio Ochoa
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gianfranco Parati .

Editor information

Editors and Affiliations

  1. Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon

    Adel E. Berbari

  2. Emeritus Professor of Medicine, University of Milano-Bicocca, Monza, Italy

    Giuseppe Mancia

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Cite this chapter

Parati, G., Lombardi, C., Narkiewicz, K., Wolf, J., Ochoa, J.E. (2018). Sleep Disturbances/Sleep Apnea. In: Berbari, A., Mancia, G. (eds) Disorders of Blood Pressure Regulation. Updates in Hypertension and Cardiovascular Protection. Springer, Cham. https://doi.org/10.1007/978-3-319-59918-2_18

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-59918-2_18

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-59917-5

  • Online ISBN: 978-3-319-59918-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation